Do analysts rate CRON or APHA?

Cronos Group currently has a consensus target price of C$4.92, indicating a potential upside of 10.24%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts clearly believe Cronos Group is more favorable than Aphria. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation and earnings, CRON or APHA?

Cronos Group has higher earnings, but lower revenue than Aphria. Aphria is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group C$179.09M 9.17 -C$32.78M C$0.19 23.47 Aphria C$611.06M 0.00 -C$637.39M -C$2.01 N/A

Do analysts recommend BHC or CRON?

Cronos Group has a consensus price target of C$4.92, indicating a potential upside of 10.24%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts prefer MJN or CRON?

Cronos Group has a consensus target price of C$4.92, indicating a potential upside of 10.24%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Cronos Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable valuation and earnings, MJN or CRON?

Cronos Group has higher earnings, but lower revenue than Cronos Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group N/A N/A N/A N/A N/A Cronos Group C$179.09M 9.17 -C$32.78M C$0.19 23.47

Do analysts rate CARA or CRON?

Cronos Group has a consensus price target of C$4.92, suggesting a potential upside of 10.24%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable earnings & valuation, CARA or CRON?

Cara Operations has higher earnings, but lower revenue than Cronos Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cara Operations N/A N/A N/A N/A N/A Cronos Group C$179.09M 9.17 -C$32.78M C$0.19 23.47

Cronos Group (CRON) Competitors

C$4.46 -0.01 (-0.22%)

As of 09/3/2026 04:00 PM Eastern

Compare

CRON vs. APHA, BHC, MJN, CARA, and DHT.UN

Should you buy Cronos Group stock or one of its competitors? Cronos Group's main competitors and comparable companies include Aphria (APHA), Bausch Health Companies (BHC), Cronos Group (MJN), Cara Operations (CARA), and DRI Healthcare Trust (DHT.UN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Cronos Group compare to Aphria?

Cronos Group (TSE:CRON) and Aphria (TSE:APHA) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

4.4% of Cronos Group shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cronos Group has higher earnings, but lower revenue than Aphria. Aphria is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$179.09M	9.17	-C$32.78M	C$0.19	23.47
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A

Cronos Group currently has a consensus target price of C$4.92, indicating a potential upside of 10.24%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts clearly believe Cronos Group is more favorable than Aphria.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company	Overall Sentiment
Cronos Group	Neutral
Aphria	Neutral

Cronos Group has a net margin of 38.95% compared to Aphria's net margin of 0.00%. Cronos Group's return on equity of 6.46% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	38.95%	6.46%	-3.73%
Aphria	N/A	N/A	N/A

Summary

Cronos Group beats Aphria on 10 of the 12 factors compared between the two stocks.

How does Cronos Group compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Cronos Group (TSE:CRON) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

Cronos Group has a consensus price target of C$4.92, indicating a potential upside of 10.24%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Cronos Group has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.85B	0.32	-C$125.65M	-C$2.94	N/A
Cronos Group	C$179.09M	9.17	-C$32.78M	C$0.19	23.47

Bausch Health Companies has a beta of 0.959729, indicating that its share price is 4% less volatile than the broader market. Comparatively, Cronos Group has a beta of 1.13355, indicating that its share price is 13% more volatile than the broader market.

10.4% of Bausch Health Companies shares are held by institutional investors. Comparatively, 4.4% of Cronos Group shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Comparatively, 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Bausch Health Companies had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Bausch Health Companies and 0 mentions for Cronos Group. Bausch Health Companies' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.

Company	Overall Sentiment
Bausch Health Companies	Neutral
Cronos Group	Neutral

Cronos Group has a net margin of 38.95% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-12.02%	87.57%	4.16%
Cronos Group	38.95%	6.46%	-3.73%

Summary

Cronos Group beats Bausch Health Companies on 10 of the 15 factors compared between the two stocks.

How does Cronos Group compare to Cronos Group?

Cronos Group (CVE:MJN) and Cronos Group (TSE:CRON) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Cronos Group has a consensus target price of C$4.92, indicating a potential upside of 10.24%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

4.4% of Cronos Group shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Cronos Group had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Cronos Group and 0 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.51 beat Cronos Group's score of 0.00 indicating that Cronos Group is being referred to more favorably in the media.

Company	Overall Sentiment
Cronos Group	Positive
Cronos Group	Neutral

Cronos Group has a net margin of 38.95% compared to Cronos Group's net margin of 0.00%. Cronos Group's return on equity of 6.46% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	N/A	N/A	N/A
Cronos Group	38.95%	6.46%	-3.73%

Cronos Group has higher earnings, but lower revenue than Cronos Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	N/A	N/A	N/A	N/A	N/A
Cronos Group	C$179.09M	9.17	-C$32.78M	C$0.19	23.47

Summary

Cronos Group beats Cronos Group on 8 of the 11 factors compared between the two stocks.

How does Cronos Group compare to Cara Operations?

Cara Operations (TSE:CARA) and Cronos Group (TSE:CRON) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

Cara Operations has higher earnings, but lower revenue than Cronos Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cara Operations	N/A	N/A	N/A	N/A	N/A
Cronos Group	C$179.09M	9.17	-C$32.78M	C$0.19	23.47

In the previous week, Cara Operations' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.

Company	Overall Sentiment
Cara Operations	Neutral
Cronos Group	Neutral

Cronos Group has a net margin of 38.95% compared to Cara Operations' net margin of 0.00%. Cronos Group's return on equity of 6.46% beat Cara Operations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cara Operations	N/A	N/A	N/A
Cronos Group	38.95%	6.46%	-3.73%

Cronos Group has a consensus price target of C$4.92, suggesting a potential upside of 10.24%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

4.4% of Cronos Group shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Cronos Group beats Cara Operations on 8 of the 9 factors compared between the two stocks.

How does Cronos Group compare to DRI Healthcare Trust?

DRI Healthcare Trust (TSE:DHT.UN) and Cronos Group (TSE:CRON) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations.

DRI Healthcare Trust has higher earnings, but lower revenue than Cronos Group. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DRI Healthcare Trust	C$172.34M	5.57	C$9.73M	-C$0.80	N/A
Cronos Group	C$179.09M	9.17	-C$32.78M	C$0.19	23.47

DRI Healthcare Trust has a beta of 0.365327, meaning that its share price is 63% less volatile than the broader market. Comparatively, Cronos Group has a beta of 1.13355, meaning that its share price is 13% more volatile than the broader market.

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Cronos Group. DRI Healthcare Trust's average media sentiment score of 1.49 beat Cronos Group's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company	Overall Sentiment
DRI Healthcare Trust	Positive
Cronos Group	Neutral

DRI Healthcare Trust currently has a consensus price target of C$25.20, indicating a potential upside of 44.33%. Cronos Group has a consensus price target of C$4.92, indicating a potential upside of 10.24%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, equities research analysts plainly believe DRI Healthcare Trust is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DRI Healthcare Trust	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Cronos Group has a net margin of 38.95% compared to DRI Healthcare Trust's net margin of 5.02%. Cronos Group's return on equity of 6.46% beat DRI Healthcare Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DRI Healthcare Trust	5.02%	2.06%	4.22%
Cronos Group	38.95%	6.46%	-3.73%

0.8% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.4% of Cronos Group shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Comparatively, 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Cronos Group beats DRI Healthcare Trust on 9 of the 17 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRON vs. The Competition

Export

Metric	Cronos Group	Pharmaceuticals Industry	Healthcare Sector	TSE Exchange
Market Cap	C$1.64B	C$12.25B	C$7.26B	C$12.57B
Dividend Yield	N/A	2.59%	2.53%	6.25%
P/E Ratio	23.47	787.27	273.29	39.47
Price / Sales	9.17	753.79	613.45	9.82
Price / Cash	1.67	94.80	77.82	82.29
Price / Book	1.49	12.33	12.89	4.71
Net Income	-C$32.78M	C$2.82B	C$3.47B	C$299.09M
7 Day Performance	-4.70%	2.59%	0.60%	-0.31%
1 Month Performance	13.20%	6.95%	5.73%	3.12%
1 Year Performance	29.28%	9.45%	25.35%	28.73%

Cronos Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
CRON Cronos Group	1.8139 of 5 stars	C$4.46 -0.2%	C$4.92 +10.2%	+28.2%	C$1.64B	C$179.09M	23.47	450
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
BHC Bausch Health Companies	0.328 of 5 stars	C$8.74 -3.2%	N/A	-8.1%	C$3.27B	C$10.85B	N/A	19,900
MJN Cronos Group	N/A	C$12.15 -1.9%	N/A	+0.0%	C$1.73B	N/A	N/A	7,600
CARA Cara Operations	N/A	N/A	N/A	N/A	C$1.62B	N/A	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:CRON) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cronos Group (CRON) Competitors

CRON vs. APHA, BHC, MJN, CARA, and DHT.UN

How does Cronos Group compare to Aphria?

Summary

How does Cronos Group compare to Bausch Health Companies?

Summary

How does Cronos Group compare to Cronos Group?

Summary

How does Cronos Group compare to Cara Operations?

Summary

How does Cronos Group compare to DRI Healthcare Trust?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cronos Group (CRON) Competitors

CRON vs. APHA, BHC, MJN, CARA, and DHT.UN

How does Cronos Group compare to Aphria?

Do insiders & institutionals believe in CRON or APHA?

Which has stronger valuation and earnings, CRON or APHA?

Do analysts rate CRON or APHA?

Does the media prefer CRON or APHA?

Is CRON or APHA more profitable?

Summary

How does Cronos Group compare to Bausch Health Companies?

Do analysts recommend BHC or CRON?

Which has higher earnings and valuation, BHC or CRON?

Which has more volatility and risk, BHC or CRON?

Do insiders and institutionals have more ownership in BHC or CRON?

Does the media favor BHC or CRON?

Is BHC or CRON more profitable?

Summary

How does Cronos Group compare to Cronos Group?

Do analysts prefer MJN or CRON?

Do institutionals & insiders have more ownership in MJN or CRON?

Does the media prefer MJN or CRON?

Is MJN or CRON more profitable?

Which has preferable valuation and earnings, MJN or CRON?

Summary

How does Cronos Group compare to Cara Operations?

Which has preferable earnings & valuation, CARA or CRON?

Does the media favor CARA or CRON?

Is CARA or CRON more profitable?

Do analysts rate CARA or CRON?

Do insiders & institutionals hold more shares of CARA or CRON?

Summary

How does Cronos Group compare to DRI Healthcare Trust?

Which has better valuation and earnings, DHT.UN or CRON?

Which has more volatility & risk, DHT.UN or CRON?

Does the media favor DHT.UN or CRON?

Do analysts rate DHT.UN or CRON?

Is DHT.UN or CRON more profitable?

Do institutionals & insiders have more ownership in DHT.UN or CRON?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools